Ann: Rhythm Completes Reagent Development Program, page-6

North & in a decent way... 6-7m EV for a potentially world class diagnostic tool for the 2nd most prevalent cancer in the world...!

The unfortunate thing about stocks like this is they get manipulated by the large accumulators who want to scoop up a major position at the expense of joe public.

Today's another classic example of capping the SP near 12-mth lows (IMO the 500,000 @ 15c sell order which was placed as soon as 250,000 @ 14.5 was bid, is a capper... & it did it's job in stalling momentum)

We know Merchant have been buying this up - so maybe they're capping to accumulate more on the cheap?

IMO within the next 12 mths, this should get to 50-60m mkt cap which would mean a SP of 50-60c given there are 100m shares on issue.

Just look at the chart for BD1 - went no where for 12 months & kept hitting lows & lows until their diagnostic tool announcement & then re-rate of 5-bags at peak...

This is the way these bio's trade - they grind you down until only the firm believers remain & then WHAMMO out comes the goods